Ventyx Biosciences, Inc.
VTYXDelisted Mar 4, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001851194
Ventyx Biosciences, Inc. was delisted on Mar 4, 2026; its insiders filed their last Form 4 on Mar 4, 2026; 139 institutions reported holding it in 13F filings for Q4 2025, worth $471.6M in total; no superinvestor held it.
Q3 2025 vs. Q2 2025
How the institutions holding Ventyx Biosciences, Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 114 | 110 | −4 |
| Shares | 44.4M | 43.9M | −574.8K (−1.3%) |
| Value | $95.1M | $136.4M | +$41.3M (+43.5%) |
New holders (19)
Institutions that held Ventyx Biosciences, Inc. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Baker Bros. Advisors LP | 1,023,130 | $3.18M | 0.02% |
| 683 Capital Management, LLC | 1,000,000 | $3.11M | 0.28% |
| Two Sigma Investments, LP | 436,082 | $1.36M | 0.00% |
| Gsa Capital Partners LLP | 242,229 | $753.0K | 0.06% |
| Schonfeld Strategic Advisors LLC | 214,189 | $666.1K | 0.00% |
| StemPoint Capital LP | 167,470 | $520.8K | 0.11% |
| Qube Research & Technologies Ltd | 146,605 | $455.9K | 0.00% |
| Citizens Financial Group Inc | 142,193 | $442.2K | 0.01% |
| Man Group plc | 80,569 | $250.6K | 0.00% |
| Diadema Partners LP | 71,204 | $221.4K | 0.15% |
| American Century Companies Inc | 69,413 | $215.9K | 0.00% |
| Exome Asset Management LLC | 60,600 | $188.5K | 0.12% |
| Woodline Partners LP | 45,826 | $142.5K | 0.00% |
| Jefferies Financial Group Inc. | 34,100 | $106.1K | 0.00% |
| Arrowpoint Investment Partners (Singapore) Pte. Ltd. | 26,858 | $83.5K | 0.12% |
| Jacobs Levy Equity Management, Inc | 19,577 | $60.9K | 0.00% |
| Persistent Asset Partners Ltd | 16,295 | $50.7K | 0.04% |
| SRS Capital Advisors, Inc. | 7,203 | $22.4K | 0.00% |
| Wealthspire Advisors, LLC | 844 | $2.63K | 0.00% |
Sold out (23)
Institutions that held Ventyx Biosciences, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Qiming U.S. Ventures Management, LLC | 412,225 | $882.2K |
| Brevan Howard Capital Management LP | 114,831 | $245.7K |
| HRT Financial LP | 91,434 | $195.0K |
| Jain Global LLC | 84,200 | $180.2K |
| UBS Oconnor LLC | 79,000 | $169.1K |
| Aster Capital Management (DIFC) Ltd | 77,338 | $165.5K |
| Y-Intercept (Hong Kong) Ltd | 69,236 | $148.2K |
| Shay Capital LLC | 56,619 | $121.2K |
| Bailard, Inc. | 41,300 | $88.4K |
| Cerity Partners LLC | 38,386 | $82.1K |
| Wealth Enhancement Advisory Services, LLC | 29,657 | $61.7K |
| Catalyst Funds Management Pty Ltd | 28,500 | $61.0K |
| Ameriprise Financial Inc | 28,031 | $60.0K |
| Palumbo Wealth Management LLC | 27,270 | $58.4K |
| Jump Financial, LLC | 24,956 | $53.4K |
| Engineers Gate Manager LP | 19,517 | $41.8K |
| Pallas Capital Advisors LLC | 17,824 | $38.1K |
| Hudson Bay Capital Management LP | 15,864 | $33.9K |
| DRW Securities, LLC | 15,637 | $33.5K |
| Mariner, LLC | 12,468 | $26.7K |
| Neuberger Berman Group LLC | 11,261 | $24.1K |
| Colony Group, LLC | 10,086 | $21.6K |
| Raymond James Financial Inc | 4,444 | $9.51K |